IRIS
DE MURO, Pierina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.785
EU - Europa 1.118
AS - Asia 808
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
SA - Sud America 7
AF - Africa 4
Totale 3.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.774
CN - Cina 546
UA - Ucraina 510
SG - Singapore 209
DE - Germania 171
IT - Italia 119
SE - Svezia 92
FI - Finlandia 83
FR - Francia 66
GB - Regno Unito 42
TR - Turchia 26
BE - Belgio 20
KR - Corea 18
CA - Canada 10
EU - Europa 8
AU - Australia 6
BR - Brasile 5
CZ - Repubblica Ceca 3
IL - Israele 3
JP - Giappone 3
PL - Polonia 3
EG - Egitto 2
HR - Croazia 2
NL - Olanda 2
AO - Angola 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
SI - Slovenia 1
TH - Thailandia 1
VN - Vietnam 1
Totale 3.737
Salva come PNG Salva come JPEG
Città #
Chandler 435
Jacksonville 316
Singapore 169
Princeton 158
Nanjing 147
Dearborn 104
Ann Arbor 83
Wilmington 72
Nanchang 65
New York 60
Sassari 59
Beijing 43
Boardman 43
Shenyang 43
Hebei 39
Woodbridge 31
Changsha 30
Ningbo 26
Tianjin 23
Izmir 22
Mountain View 22
Hangzhou 21
Brussels 20
Jinan 19
Seoul 18
Jiaxing 17
Santa Clara 17
Zhengzhou 17
Kunming 14
Andover 13
Norwalk 13
Ashburn 10
Toronto 9
San Francisco 8
Guangzhou 7
Villiers-sur-marne 7
Auburn Hills 6
Helsinki 6
Lanzhou 6
Los Angeles 6
Taizhou 6
Changchun 5
Shanghai 4
Brno 3
Falls Church 3
Melbourne 3
Molfetta 3
Paris 3
Verona 3
Warsaw 3
Cagliari 2
Cairo 2
Canberra 2
Cedar Knolls 2
Edinburgh 2
Fairfield 2
Fuzhou 2
Hanover 2
London 2
San Jose 2
San Mateo 2
Serramanna 2
São Paulo 2
Tappahannock 2
Tel Aviv 2
Tokyo 2
Turin 2
Zagreb 2
Adelaide 1
Agadir 1
Americo Brasiliense 1
Amsterdam 1
Augusta 1
Bangkok 1
Berlin 1
Chernihiv 1
Denver 1
Ficarazzi 1
Fredericton 1
Haifa 1
Haikou 1
Hanoi 1
Leawood 1
Lima 1
Ljubljana 1
Mexico City 1
Miami 1
Milan 1
Munich 1
New Plymouth 1
Oristano 1
Potenza 1
Rome 1
Sofia 1
Wuxi 1
Totale 2.323
Salva come PNG Salva come JPEG
Nome #
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 77
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 75
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 70
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 68
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 66
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 66
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 66
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 65
Hb G-Philadelphia, or [alpha68(E17)AsnLys], in North Sardinia: detection by isoelectric focusing and HPLC of tryptic peptides 64
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 64
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 63
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 62
Haematological and biosynthetic features of beta°-thalassemia with an associated alpha-thalassemia heterozygosity in Sardinia 61
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 59
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 59
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 56
Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity 56
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 56
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 55
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 55
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 54
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 54
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 53
A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients 53
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 52
Urinary excretion of GAGs during hypocholesterolemic therapy 52
Apolipoprotein Profiles in Atherosclerotic Disease 49
Role of the small proteoglycan bikunin in human reproduction 49
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 49
Apolipoprotein Profiles in Atherosclerotic Disease 49
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 49
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 48
Buoyant density of Lp(a) subclasses in hypercholesterolemia 48
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 47
Ruolo dei proteoglicani nella medicina della riproduzione 47
GAG and protein composition of GAG-protein complexes from normal human plasma 46
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 46
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 46
Proteoglicani e diabete gestazionale: dati preliminari 46
Atherosclerotic modifications of human proteoglycans 45
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 45
Urinary glycosaminoglycan composition in chronic glomerulonephritis 45
Urinary transaforming growth factor beta 1 in various types of nephropathy 44
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 44
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 44
Glycosamynoglycan diversity in sponge extracellular matrix 43
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 43
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 43
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 43
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 42
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 42
Urinary glycosaminoglycansin patients with systemic lupus erytematosus 41
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 41
Investigations on PGs extracted from human aorta of different age and with different atherosclerotic lesions 41
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 41
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 41
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 41
The gamma globin chain heterogeneity of the Sardinian newborn baby 40
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 40
Urine bikunin as a marker of renal impairment in Fabry's disease 40
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 40
Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes 40
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 39
Modification of low density lipoprotein induced by the interaction with standard GAGs 38
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 37
Diversità molecolare negli invertebrati marini: screening dei glicosaminoglicani in spugne del Mediterraneo occidentale 37
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 36
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 36
Glycosaminoglycans and fabry’s disease 35
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 35
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 34
Glycosaminoglycan diversity in sponge extracellular matrix 33
Hematological and biosynthetic features of betao-thalassemia with an associated beta-thalassemia heterozygosity in Sardinia. 33
Urinary transforming growth factor-beta 1 in various types of nephropathy 32
Human LDL binding to plasma high charge glycosaminoglycan-protein complexes 32
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 31
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 30
Sulphated polysaccharide content and localization in some marine sponge species. 29
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 29
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 27
Totale 3.772
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.544
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020537 0 0 0 0 89 89 133 10 89 31 96 0
2020/2021606 84 5 98 8 82 19 85 4 95 98 16 12
2021/2022396 62 3 0 11 6 2 24 26 46 25 39 152
2022/2023802 84 54 14 149 82 141 0 93 130 9 28 18
2023/2024227 45 19 7 4 48 50 1 11 0 1 23 18
2024/2025265 18 17 128 30 72 0 0 0 0 0 0 0
Totale 3.772